학술논문

Idelalisib treatment is associated with improved cytopenias in patients with relapsed/refractory iNHL and CLL
Document Type
Journal
Source
BRITISH JOURNAL OF HAEMATOLOGY; APR 2016, 173 p99-p100, 2p. Supplement: 1
Subject
Language
English
ISSN
13652141